ID 1769 - Kwas gamma-linolenowy

PL: Kwas gamma-linolenowy
EN: Gamma linolenic acid (GLA)
Pdf:

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituents that are the subject of the health claims are "gamma-linolenic acid (GLA; C18: 3n-6) provided by evening primrose oil and/or borage (starflower) oil", "gamma-linolenic acid", "evening primrose oil (Oenothera biennis) contains gamma-linolenic acid", "borage oil (GLA= gamma linolenic acid)", "oenothera biennis-evening primrose-seeds oil", "long chain omega 6 polyunsaturated fatty acid GLA (gamma-linolenic acid)", "Borago officinalis", and "GLA (example from Borago officinalis, primrose oil, black currant seed oil)".
In the context of the proposed health relationships, wordings, conditions of use, and the clarifications provided by Member States, the Panel assumes that the food constituent that is the subject of the health claims is gamma-linolenic acid (GLA).
GLA is a n-6 long-chain polyunsaturated fatty acid which is present in small amounts in a variety of foods of both plant and animal origin and which can also be synthesised in the human body from its precursor linoleic acid (LA). GLA is a well recognised nutrient and can be measured in foods by established methods. This evaluation applies to GLA from all sources.
The Panel considers that the food constituent, gamma-linolenic acid (GLA), which is the subject of the health claims, is sufficiently characterised.

2.6. Funkcje błon komórkowych (ID 1769)

The claimed effect is "function of the cell membrane". The Panel assumes that the target population is the general population.
Cell membranes may have different structures and functions depending on their composition and the cell type to which they belong. The Panel notes that several properties of cell membranes have been mentioned in the proposed wordings and that a specific effect related to the function of cell membranes has not been identified.
The Panel considers that the claim is general and non-specific and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.

Warunki i możliwe ograniczenia stosowania oświadczenia

GLA 117- 440 mg / Evening primrose oil – 1,3 -2,6 g / Borage oil – 1-2g